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Beyond the Hospital
Doors – The Future of
Transitions of Care
Lorena Berrios Caldero
PGY-1 Pharmacy Resident
West Kendall Baptist Hospital

Objectives
1. Define transitions of care (TOC) and the
pharmacist’s role during this process
2. Identify challenges present in the process
of transitioning patients from secondary
to primary care
3. Describe strategies for the optimization
of TOC services after hospital discharge
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Transitions of Care
The movement of
patients between health
care practitioners,
settings and home as
their condition and care
needs change.

https://www.jointcommission.org/assets/1/18/Hot_Topics_Transitions_of_Care.pdf
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Importance


The need for effective patient discharge
from the hospital is increasing because of:






Rising number of transitions of elderly and
chronically ill patient between various
healthcare institutions
Shorter hospital stays
Growing effort to deliver care in the
community
4
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Regulatory and Financial
Impact on Hospitals
The Patient Protection and Affordable Care Act


Penalties enacted on hospitals with high readmission rates:








2012: Heart failure, myocardial infarction, and pneumonia
2015: Total hip and knee replacements and chronic obstructive
pulmonary disease (COPD) exacerbations
2017: Coronary artery bypass graft (CABG)

For 2019, penalties based on a hospital’s performance
relative to other hospitals treating a similar proportion of
Medicare patients

https://catalyst.nejm.org/hospital-readmissions-reduction-program-hrrp/
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http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html

Regulatory and Financial
Impact on Hospitals
Centers for Medicare and Medicaid Services
(CMS)


2013: 1% penalization for hospital readmission



2015: Increased penalties to 3%

The Joint Commission


National Patient Safety Goal 03.06.01


Maintain and communicate accurate patient
medication information

http://www.jointcommission.org/core_measure_sets.aspx
https://catalyst.nejm.org/hospital-readmissions-reduction-program-hrrp/
http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Readmissions-Reduction-Program.html
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Challenges in TOC
Communication

Medicationrelated
Challenges

Patient
Education

Accountability

https://www.jointcommission.org/assets/1/18/Hot_Topics_Transitions_of_Care.pdf
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Communication
Breakdowns


Expectations differ between senders and
receivers of patients in transition



Culture does not promote successful
hand-off



Lack of standardized procedures



Inadequate amount of time provided for
successful hand-off

https://www.jointcommission.org/assets/1/18/Hot_Topics_Transitions_of_Care.pdf
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Patient Education
Breakdowns
 Lack

of understanding of the medical
condition or the plan of care

 Exclusion

of patients/caregivers from
the planning of transition process

 Conflicting

recommendations and
unclear instructions

https://www.jointcommission.org/assets/1/18/Hot_Topics_Transitions_of_Care.pdf
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Accountability
Breakdowns


No provider or clinical entity takes
responsibility of coordinating care across
settings



Multiple providers involved in patient’s care


Every year, the average elderly patient sees 7
physicians

https://www.jointcommission.org/assets/1/18/Hot_Topics_Transitions_of_Care.pdf

14

Medication-Related
Challenges


Inaccurate documentation during hospital stay



Prescribing errors



Inaccurate medication profile at discharge



Polypharmacy





Inadequate patient education on discharge
medications
Failure to provide patient follow-up
15

Deficits in Communication and Information
Transfer Between Hospital-Based and
Primary Care Physicians: Implications for
Patient Safety and Continuity of Care



Evaluate the prevalence of deficits in
communication and information transfer
Information related to
medications missing
from discharge
summary 40% of the
time

Medication-related problems

Low availability of
discharge summary
for outside provider
to review increased
prescribing errors

Communication breakdowns

Patient or family
counseling (92%)
and follow-up plan
(43%) not available

Patient education breakdowns

Kripalani S, LeFevre F, Phillips CO, et. al. Deficits in communication and information transfer between hospital-based and
7primary care physicians: implications for patient safety and continuity of care. J Amer Med Assoc. 2007;297(8):831-841.
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Implications to Patient
Outcomes


One in 5 patients has an adverse event
after hospital discharge



Approximately 62% of these adverse
events are preventable



More than 60% of hospital readmissions
occur as a result of medication-related
problems that are unresolved at hospital
discharge

https://catalyst.nejm.org/hospital-readmissions-reduction-program-hrrp/
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Pharmacist’s Role


During discharge:






Immediately post-discharge:





Medication reconciliation
Patient education and communication
Meds to beds
Follow-up phone calls
Post-discharge clinics

In clinics:



MTM visits
Provider collaboration
18

Patient Case


63 year old female with a past medical history of
Chronic Obstructive Pulmonary Disease admitted to
the hospital due to an exacerbation



Smokes 1 pack per day and states she does not use
the inhalers prescribed by her doctors



During her hospital stay she was educated on the
importance of smoking cessation and medication
adherence to prevent further
exacerbations



After 5 days in the hospital, she is
ready to go home
19

Medication Reconciliation


The comprehensive evaluation of a patient’s
medication regimen any time there is a change in
therapy in an effort to avoid medication errors
such as:







Omissions
Duplications
Dosing errors
Drug interactions

Observe a patient’s compliance and adherence
patterns

https://www.pharmacist.com/sites/default/files/files/2012_improving_care_transitions.pdf
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Medication Reconciliation
Medication Reconciliation at Hospital Discharge:
Evaluating Discrepancies
Objective

Methods

Results

Conclusion

•To identify, characterize, and assess the clinical impact of unintentional
medication discrepancies at hospital discharge.

•Assessment of medication discrepancies through comparison of a best possible
medication discharge list with the actual discharge prescriptions.

•From the 150 patients included in the study, 106 (70.7%) had at least one
unintentional discrepancy.

•Structured medication reconciliation may help to prevent discharge medication
discrepancies.
Wong JD, et. al. Ann Pharmacother. 2008; 42:1373-1379.

21

Discharge Counseling
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Discharge Counseling
Role of Pharmacist Counseling in Preventing Adverse
Drug Events After Hospitalization
•To identify drug related problems during and after hospitalization and to
determine the effect of patient counseling and follow-up by pharmacist on
preventable ADEs.
Objective

Methods

Results

Conclusion

•Patients were randomized into the control group (n=84) who received usual
care or the intervention group (n=92) who received discharge counseling by a
pharmacist.

•At 30 days after discharge, preventable ADEs were detected in 11% of
patients in the control group and 1% of patients in the intervention group
(p=0.01)

•Discharge counseling by a pharmacist was associated with a lower rate of
preventable ADEs 30 days after hospital discharge.
Schnipper JL, et al. Arch Intern Med. 2006;166:565-571.
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Meds to Beds


Hand-delivery of prescriptions to hospital
patients at bedside before discharge



Identification and resolution of potential
barriers to compliance prior to hospital
discharge





Medications not covered by insurance
High co-pays
Coordination of prior authorizations
Transportation

https://www.pharmacist.com/article/meds-beds-programs-prevent-rehospitalization
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Meds to Beds
The average time to fill these
prescriptions is 20 minutes

Has been shown to decrease
readmission rates
Potential for the pharmacy
providing the service to
retain the customer
https://www.cardinalhealth.com/content/dam/corp/web/documents/brochure/Cardinal-Health-CaseStudy-Hackensack-Bedside.pdf
https://www.mckesson.com/blog/pharmacists-partnering-with-hospitals-to-improve-outcomes/
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Patient Case


Patient was discharged on Spiriva and Symbicort



She had been using nicotine patches during her hospital stay
and stated she was ready to quit smoking and the patches had
helped her



During medication reconciliation, the discharge pharmacist
noticed there were no nicotine patches in the patient’s
medication list



After talking to the doctor and getting a
prescription for nicotine patches, the
discharge pharmacist went to the
patient’s room and provided counseling
regarding inhaler technique and proper
patch use.
26

Beyond the hospital doors!

Bridging the gap in care…

Follow-up Phone Calls


The pharmacist calls the patient usually
72 hours after discharge


Concerns related to medications



Problems accessing medications



Patient education reinforcement



Follow-up reminder

28

Follow-up Phone Calls
A Reengineered Hospital Discharge Program to
Decrease Rehospitalization: A Randomized Trial
Objective

Methods

Results

Conclusion

•To test the effects of an intervention designed to minimize hospital utilization
after discharge.

•Patients were randomly assigned to the intervention group where they
received a follow-up phone call by a clinical pharmacist 2-4 days after
discharge or to the control group where they received usual care.

•Participants in the intervention group had a lower rate of hospital utilization
than those receiving usual care (0.314 vs 0.451 visits/person/month;
p=0.009).

•Follow-up phone calls by a clinical pharmacist minimize hospital utilization
after discharge.
Jack BW, et. al. Ann Intern Med. 2009;150(3):178-187.
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Follow-up Phone Calls
Post-discharge Pharmacist Medication Reconciliation:
Impact on Readmission Rates and Financial Savings
•To assess the impact of ambulatory clinical pharmacist medication therapy
assessment and reconciliation for patients post-discharge in terms of hospital
readmission rates, financial savings, and medication discrepancies.
Objective

Methods

Results

Conclusion

•Patients in the intervention group received a phone call from a pharmacist 3-7
days post-discharge and patients in the comparison group did not receive
clinical pharmacist intervention.
• Patients in the intervention group had decreased readmission rates at 7 (0.8% vs. 0.4%;
p=0.01), 14 (5% vs 9%; p=0.04), and 30 (12% vs 14%; p=0.29) days post-discharge
• Financial savings for patients in the intervention group was estimated to be more than
$1,500,000 annually

•Medication assessment and reconciliation by pharmacist 3-7 days postdischarge can decrease readmissions and provide cost-savings
Kilcup M, et. al. J Am Pharm Assoc. 2013;53:78-84.
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Post-Discharge Clinics
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Post-Discharge Clinics
Pharmacist-Coordinated Multidisciplinary Hospital
Follow-up Visits Improve Patient Outcomes
•To compare hospital readmission rates and interventions in a multidisciplinary
team visit coordinated by a clinical pharmacist practitioner with those
conducted by a physician-only team within an internal medicine hospital
Objective
follow-up program.

Methods

•Retrospective review of follow-up visits within 7 days of discharge performed
by a multidisciplinary team (physician and pharmacist) vs a physician-only
team.

Results

•Patients seen by the multidisciplinary team had a 30-day readmission rate of
14.3% compared with 34.3% by the physician-only team (p=0.010).
•Interventions were higher in the multidisciplinary team

•Hospital follow-up visits coordinated by the multidisciplinary team decreased
30-day hospital readmission rates compared with follow-up visits by a
physician-only team.
Conclusion
Cavanaugh JJ, et. al. J Manag Care Spec Pharm. 2015;21(3):256-260.
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Post-Discharge Clinics
Evaluation of Pharmacist Involvement in Outpatient
Transitions of Care
•To assess the impact of pharmacist involvement on the identification and
resolution of medication discrepancies during post-discharge follow-up
appointments.
Objective

Methods

Results

•Retrospective: patients discharged from the hospital who already had a followup visit without a pharmacist
•Prospective: patients discharged from the hospital who had a follow-up visit
scheduled with a pharmacist
•An increase of 6.2 discrepancies addressed per patient (3.4 in the
retrospective analysis vs 9.6 in the prospective population; p=0.0003)

•Pharmacist involvement in outpatient-based transitions of care process
significantly increased medication discrepancies addressed by the patient’s
PCP following discharge from the hospital to home.
Conclusion
Whalley AS, et. al. J Gen Intern Med. 2018;33(8):1227-1228.
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Patient Case


72 hours after discharge, the pharmacist called the
patient to reinforce what they had talked about during
discharge counseling and to make sure the patient
was not experiencing any problems



The patient stated that she was not able to get one of
the inhalers because her insurance did not cover it.
After looking into it, the pharmacist noticed a prior
authorization was needed.



Prior authorization process was
initiated and follow-up appointment
was confirmed with the patient
34

MTM Visits
Medication Therapy Management (MTM)


A range of services provided to individual
patients to optimize therapeutic outcomes and
detect and prevent costly medication problems






Review of all medications prescribed by all
prescribers providing care to the patient
Medication-related education
Collaboration with healthcare providers to develop
and achieve optimal goals

https://www.accp.com/docs/govt/advocacy/Leadership%20for%20Medication%20Management%20-%20MTM%20101.pdf

35

Pharmacist-led MTM Clinics
The Effect of Clinical Pharmacist-Led Comprehensive Medication
Management on Chronic Disease State Goal Attainment in a PatientCentered Medical Home
•To assess the effect of pharmacist-led comprehensive medication management
(CMM) on therapeutic goal attainment rates for glycemic, blood pressure, and
dyslipidemia outcomes.
Objective

Methods

Results

Conclusion

•Patients managed within the primary care network who had diabetes were
included in the intervention group that was compared to a control group made
up of patients who didn’t have access to a primary care network pharmacist.

•Patients in the intervention group had significantly higher rates of goal
attainment for the 3 endpoints (p<0.001)

•Addition of CMM services provided by a clinical pharmacist had a positive
effect on therapeutic goal attainment rates for patient with diabetes.
Prudencio J, et al. J Manag Care Spec Pharm. 2018;24(5):423-429.
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Community Pharmacist
and MTM
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Community Pharmacist


Often the first member of the health care team
that interacts with the patient post-discharge



Evidence supports that community pharmacists
can:


Identify and resolve medication-related problems



Reduce 30-day readmission rates



Reduce ED utilization

Melody KT, McCartney E, Sen S, et. al. Optimizing care transition: the role of the community pharmacist. Integ
Pharm Research and Prac. 2016;5:43-51.
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Community Pharmacist
TransitionRx: Impact of community pharmacy post-discharge
medication therapy management on hospital readmission rate
•To determine if a community pharmacy-based TOC program that includes the
full scope of MTM services decreases hospital readmissions, resolves
medication-related problems, and increased patient satisfaction.
Objective

Methods

Results

Conclusion

•Patients discharged from the hospital with a diagnosis of CHF, COPD, or
pneumonia were recruited and referred to the community pharmacy for MTM
services with the pharmacist within 1 week of discharge

•20% of patients in the usual care group were admitted to the hospital within
30 days compared with 6.9% of patients in the intervention group (p=0.019)

•Community pharmacies successfully collaborate with hospitals to develop a
referral process for TOC interventions
Luder HR, et. al. J Am Pharm Assoc. 2015;55(5):246-254.
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Community Pharmacist can
have impact beyond MTM

Discrepancies
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Barriers to Implementing
TOC in the Community


The biggest concern for community
pharmacists is the time required to
provide TOC services


Workflow changes



Delegation of task to appropriate personnel

Melody KT, McCartney E, Sen S, et. al. Optimizing care transition: the role of the community
pharmacist. Integ Pharm Research and Prac. 2016;5:43-51.
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Telepharmacy


Has been shown to overcome barriers to
health services caused by access to care



Technology already available

Lee AC, et al. Inform Prim Care. 2012;20(4):263-260.
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Provider Collaboration
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Collaborative Practice
Agreements


Create a formal practice relationship between a
pharmacist and other health care providers



Specify what patient care services can be
provided



Allow physician and pharmacists to share
responsibility for patient outcomes



State laws and regulations authorizing CPAs are
highly variable

Joseph T, et. al. J Manag Care Spec Pharm. 2017;23(5):541-548.
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Provider Collaboration
A Review of Advances in Collaborative Pharmacy Practice to
Improve Adherence to Standards of Care in Diabetes
Management


Settings with collaborative practice agreement between
pharmacists and physicians achieve better HbA1C control

HbA1C reduction ≥1%: 79% (n=28)

HbA1C reduction ≥2%: 100% (n=9)



Improvement in adherence to ADA recommendations of
screenings for:
• Retinopathy
• Neuropathy
• Microalbuminuria

Conley MP, et. al. Curr Diab Rep. 2014;14:470-477.
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Patient Case


Patient went to her follow-up visit one week
after being discharged and was able to get
her inhaler



She stated she had been able to reduce the
number of cigarettes she smokes to ½ pack
per day, but needs more than nicotine
patches to help her entirely quit



Her PCP referred her to a
pharmacist-led smoking
cessation clinic
46
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Financial Support
 Cost-avoidance
 Reimbursement





MTM
TOC*
Chronic Disease Management*
Incidence to (hospital-based clinic)

*Requires a collaborative agreement with a physician
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Provider Status


Will allow pharmacist to bill for their
services independently



Will improve patient access to pharmacist
provided services



Will help overcome barriers in
incorporating pharmacists as integral
members of interdisciplinary teams in the
ambulatory setting

https://www.pharmacist.com/provider-status-what-pharmacists-need-know-now
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Closing Thoughts
Pharmacist engagement in transitions of care progress…

…BUT

there is more to do!

Pedersen CA, et al. AM J Health-Syst Pharm. 2017;74(17):1336-52.
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Closing Thoughts


Elements for effective transitions of care:


Multidisciplinary support and collaboration



Effective integration of the pharmacy team



Data available to justify resources





Electronic patient information and data
transfer
Strong partnership network
51

Self-assessment

True or False
1.

Pharmacists’ role in TOC is limited to the
inpatient setting.

2.

Harm from prescribed or omitted medications is
higher after patients have been discharged from
the hospital, mainly as a result of lack of
communication between providers.

3.

Implementation of TOC is well established in the
inpatient setting. However, there is room for
improvement in the TOC process once patients
move to the outpatient setting.
53

Thank You!
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